Bridging the gap to reduce surgical site infections.
F. Overdyk
DOI: https://doi.org/10.1213/ANE.0b013e3181ee85b1
2010-10-01
Abstract:Surgical site infections (SSI) remain one of the most persistent and costly preventable complications in health care. Although as anesthesiologists, we may perceive our responsibility limited to the timely administration of prophylactic antibiotics and sterile placement of invasive catheters, we feel the pain of our surgical colleagues when their service suffers a rash of SSI, and they resort to strategies ranging from ones with sound scientific basis to mere superstition. Over the years, I have seen operating rooms undergo lockdowns worthy of a maximum-security prison, bathed in dance club–like ultraviolet light, or transformed to resemble a spacewalk rehearsal. Yet the problem of SSI persists, second only to urinary tract infections among the most common types of nosocomial infections in hospitals. Approximately 1 in 50 surgical procedures are complicated by SSI, which translates to an estimated 290,485 cases annually, of which 13,088 result in death. It is no surprise that SSI have made the 2010 Joint Commission National Patient Safety Goals for the second consecutive year.* The importance of high tissue oxygen levels in improved surgical outcomes and reduced surgical infection rates has been understood for many years. High tissue oxygen concentrations enhance the effects of leukocytes and antibiotics on microbes and are indicative of adequate tissue perfusion. Oxygen delivery to the tissues, a function of both bloodflow and oxygen-carrying capacity, has been the underpinning of many of the nonpharmacologic strategies to prevent surgical wound infection. Traditionally, liberal intraoperative fluid management was thought to improve outcomes by improving perfusion, yet more recent data suggest that tissue edema from overly aggressive hydration may be detrimental. We remain without a consensus on the optimal volume replacement strategy for optimal surgical outcomes. Similarly, although the sympathectomy accompanying regional anesthesia improves tissue perfusion and certain outcomes (such as preserved graft patency in vascular surgery and decreased incidence of deep vein thrombosis), its impact on SSI is unclear. Avoiding intraoperative hypothermia helps maintain tissue perfusion, reduces SSI, and shortens hospitalization. Mild intraoperative hypoventilation has been shown to increase tissue oxygen levels due to the vasodilating effect of carbon dioxide in obese patients. More clarity may be brought to the optimal intraoperative fluid, temperature, ventilation, and oxygenation strategies that minimize SSI if we could easily measure subcutaneous tissue oxygen partial pressure (Sto2). Arguably, Sto2 represents the common pathway of cellular “contentment” during the “decisive period,” which is defined as the hours surrounding surgical incision in which prophylactic antibiotics have been shown to have the greatest impact on reducing SSI. In this issue of Anesthesia & Analgesia, Govinda et al. use a noninvasive infrared spectroscope (NIRS) to measure Sto2 as a predictor of SSI that manifests as late as 30 days postoperatively. The authors used a receiver operator curve to optimize the sensitivity and specificity of upperarm Sto2 measurements to differentiate patients who develop an SSI from those who do not. They found Sto2 below 66% measured 75 minutes after colonic surgery on the upper arm to be predictive for SSI diagnosed, on average, 9 days after surgery. This NIRS measurement was a better predictor for SSI than were 2 clinically accepted SSI risk assessment metrics, the National Nosocomial Infections Surveillance System and Study on the Efficacy of Nosocomial Infection Control. As an introductory study on this technology, its limitations are several and well delineated in the article. However, if this result is reproducible upon further investigation, we may have an important “early warning system” for SSI and a tool with which to dissect the problem of SSI into 2 components. First, this noninvasive technique may allow us to investigate the different intraoperative anesthetic strategies involving fluid management, ventilation, oxygenation, hemodynamic indices, and temperature that optimize Sto2 during the immediate postoperative period. Second, once we optimize and control for Sto2, we can explore additional postoperative strategies to minimize SSI. The current debate on the efficacy of high intraoperative and postoperative Fio2 in reducing SSI demonstrates in which cases this Sto2 measurement may be helpful. A recent meta-analysis of 5 randomized, double-blind clinical trials found a relative risk reduction for SSI of 33% when hyperoxic gas mixtures (Fio2 80%) were used intraoperatively and immediately postoperatively for 2 to 6 hours versus a normoxic (Fio2 30%) mixture. Yet, few anesthesiologists and surgeons have adopted this approach, perhaps because a benefit realized only once in every 33rd patient (number needed to treat) may not justify the inconvenience and risks of *From http://www.jointcommission.org/PatientSafety/NationalPatient SafetyGoals/.